Posaconazole and Amphotericin B Combination Therapy against Cryptococcus neoformans Infection
To investigate the effects of posaconazole (POS) and amphotericin B (AMB) combination therapy in cryptococcal infection, we established an experimental model of systemic cryptococcosis in CD1 mice by intravenous injection of three distinct clinical isolates of Cryptococcus neoformans. Therapy was st...
Salvato in:
| Pubblicato in: | Antimicrob Agents Chemother |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology (ASM)
2004
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC514762/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15328090/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.9.3312-3316.2004 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
